Drug Trial Radar · NCT05908825
Placebo-Controlled Study Assessing the Use of a Novel Exfoliative Serum With A Chemical Peel to Improve Photodamage in Adults
Last checked: Nov 20, 2026Latest source record: Jul 19, 2024 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
34
Actual
Start
Jun 22, 2023
Primary completion
Nov 16, 2023
Study completion Jan 26, 2024
Sponsor
- Lead sponsor
- Austin Institute for Clinical ResearchResearch network
- Sponsor type
- Research network
- Collaborators
- SkinCeuticals
- First posted
- Jun 18, 2023
Design
- Study type
- Interventional
- Phase
- Not applicable
- Allocation
- Randomized
- Model
- Sequential
- Masking
- Double (participant, investigator)
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- Female only, from 30 years, up to 65 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
This is a split-face, double-blind, placebo-controlled study assessing the use of a novel exfoliative serum with a chemical peel to improve photodamage in healthy female subjects between the ages of 30 and 65 years, inclusive, with Fitzpatrick skin types I-VI.
Conditions
- Photodamaged Skin
Interventions
Vitamin C with AHA Exfoliative SerumDrug
Catalyst is a novel skincare product comprised of low concentrations of multiple hydroxy acids and will be randomly assigned as Product A or Product B to be applied to one side of the face.
Placebo serumDrug
Placebo serum will be randomly assigned as Product A or Product B to be applied to one side of the face.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Change in Product tolerabilityTime frame: Change from Baseline at Day 42
- Change in Product efficacyTime frame: Change from Baseline at Day 42
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Austin Institute for Clinical Research, Inc.
Pflugerville, Texas
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.